HRMY FY 2019 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M

Gross Profit

$4M73.7% margin

Operating Income

-$146M-2433.8% margin

Net Income

-$152M-2535.1% margin

EPS (Diluted)

$-2.94

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$76M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$107M

Total Liabilities

$118M

Stockholders' Equity

-$12M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$0	—
Gross Profit	$4M	-$184,000	+2501.1%
Operating Income	-$146M	-$41M	-252.1%
Net Income	-$152M	-$40M	-280.9%